Shionogi & Co., Ltd. is pleased to announce that JEIL PHARMACEUTICAL CO., LTD., its partner in South Korea, has obtained marketing approval from the South Korean regulatory authorities for the gram-negative bacterial infection treatment “Fetroja®“(cefiderocol).
Shionogi Press Release